🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/11/2014 | 56,98 | 57,20 | 56,50 | 56,65 | +0,95% | 1,24% | 13.942.173 |
| 10/11/2014 | 55,57 | 56,48 | 55,06 | 56,12 | -0,89% | 2,56% | 15.299.228 |
| 07/11/2014 | 56,67 | 56,89 | 56,36 | 56,62 | +0,13% | 0,94% | 11.122.424 |
| 06/11/2014 | 56,87 | 57,16 | 56,48 | 56,55 | -0,52% | 1,19% | 14.003.481 |
| 05/11/2014 | 57,24 | 57,49 | 56,66 | 56,84 | +0,34% | 1,45% | 13.287.382 |
| 04/11/2014 | 56,17 | 56,98 | 56,17 | 56,65 | +0,76% | 1,43% | 11.882.643 |
| 03/11/2014 | 55,30 | 56,23 | 54,93 | 56,22 | +1,69% | 2,35% | 10.667.487 |
| 31/10/2014 | 55,30 | 55,47 | 55,02 | 55,29 | +1,10% | 0,81% | 14.741.273 |
| 30/10/2014 | 53,16 | 54,76 | 53,15 | 54,69 | +1,97% | 3,03% | 13.484.197 |
| 29/10/2014 | 53,45 | 54,02 | 53,08 | 53,63 | +0,63% | 1,75% | 13.092.559 |
| 28/10/2014 | 54,01 | 54,01 | 51,62 | 53,29 | -1,06% | 4,42% | 25.111.338 |
| 27/10/2014 | 54,30 | 54,62 | 53,36 | 53,86 | -2,01% | 2,32% | 15.111.007 |
| 24/10/2014 | 54,20 | 55,02 | 54,04 | 54,97 | +1,73% | 1,81% | 8.966.059 |
| 23/10/2014 | 53,68 | 54,46 | 53,62 | 54,04 | +2,02% | 1,56% | 12.419.953 |
| 22/10/2014 | 52,70 | 53,30 | 52,48 | 52,97 | +0,69% | 1,56% | 13.520.982 |
| 21/10/2014 | 52,07 | 52,75 | 51,83 | 52,61 | +2,00% | 1,76% | 18.119.815 |
| 20/10/2014 | 51,74 | 51,78 | 51,45 | 51,57 | +0,06% | 0,65% | 12.643.177 |
| 17/10/2014 | 51,38 | 52,13 | 51,08 | 51,55 | +1,10% | 2,04% | 20.664.569 |
| 16/10/2014 | 51,54 | 51,61 | 50,09 | 50,98 | -2,38% | 2,96% | 22.905.298 |
| 15/10/2014 | 52,83 | 53,31 | 51,80 | 52,22 | -2,84% | 2,85% | 19.687.518 |
| 14/10/2014 | 53,98 | 54,34 | 53,18 | 53,75 | +0,34% | 2,16% | 11.460.718 |
| 13/10/2014 | 55,87 | 55,87 | 53,42 | 53,57 | -4,30% | 4,39% | 15.518.470 |
| 10/10/2014 | 56,59 | 57,18 | 55,97 | 55,97 | -0,93% | 2,12% | 11.826.890 |
| 09/10/2014 | 57,25 | 57,74 | 56,40 | 56,50 | -1,61% | 2,33% | 9.008.398 |
| 08/10/2014 | 55,97 | 57,47 | 55,89 | 57,42 | +2,94% | 2,83% | 12.909.474 |
| 07/10/2014 | 56,60 | 56,68 | 55,77 | 55,78 | -1,88% | 1,60% | 9.977.065 |
| 06/10/2014 | 57,41 | 57,49 | 56,58 | 56,85 | -0,53% | 1,58% | 7.456.101 |
| 03/10/2014 | 56,46 | 57,35 | 56,46 | 57,16 | +1,78% | 1,57% | 9.056.606 |
| 02/10/2014 | 56,09 | 56,36 | 55,62 | 56,15 | +0,24% | 1,31% | 8.499.070 |
| 01/10/2014 | 56,38 | 56,51 | 55,82 | 56,02 | -0,96% | 1,22% | 9.525.167 |